Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delay Discounting as a Target for Self-Regulation in Prediabetes

NCT03664726 is registered in ClinicalTrials.gov with Leonard Epstein as lead sponsor.

NCT NCT03664726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03664726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delay Discounting as a Target for Self-Regulation in Prediabetes
Lead sponsor
Leonard Epstein
Phase
Not applicable
Overall status
Completed
Start date
February 12, 2018
Completion date
June 30, 2018
Enrollment
78 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetes